Variant report
Variant | esv3324472 |
---|---|
Chromosome Location | chr9:117595211-117598982 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374127487 | chr9:117595325-117595326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546184915 | chr9:117595353-117595354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560234552 | chr9:117595392-117595393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562621187 | chr9:117595526-117595527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76122810 | chr9:117595602-117595603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35082832 | chr9:117595683-117595684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552350699 | chr9:117595698-117595699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6478110 | chr9:117595728-117595729 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs10982419 | chr9:117595770-117595771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189143251 | chr9:117595793-117595794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560449127 | chr9:117595899-117595900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs180674061 | chr9:117595907-117595908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138786251 | chr9:117595920-117595921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575032738 | chr9:117595928-117595929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527693813 | chr9:117595953-117595954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140931749 | chr9:117595963-117595964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377139731 | chr9:117595987-117595988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553054131 | chr9:117595991-117595992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573291515 | chr9:117596026-117596027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76966576 | chr9:117596060-117596061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559119033 | chr9:117596134-117596135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6478111 | chr9:117596180-117596181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs544374912 | chr9:117596197-117596198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561293064 | chr9:117596216-117596217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574782790 | chr9:117596227-117596228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142049493 | chr9:117596247-117596248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145672779 | chr9:117596300-117596301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532251696 | chr9:117596304-117596305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552021905 | chr9:117596314-117596315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562582397 | chr9:117596320-117596321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs386737874 | chr9:117596350-117596351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1853187 | chr9:117596352-117596353 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs190885525 | chr9:117596369-117596370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550032590 | chr9:117596430-117596431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183459243 | chr9:117596439-117596440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138046202 | chr9:117596450-117596451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149504318 | chr9:117596542-117596543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566716367 | chr9:117596563-117596564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539005874 | chr9:117596577-117596578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558809012 | chr9:117596582-117596583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575328407 | chr9:117596593-117596594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186008515 | chr9:117596616-117596617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554701433 | chr9:117596698-117596699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568220469 | chr9:117596757-117596758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144187516 | chr9:117596818-117596819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148689902 | chr9:117596838-117596839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554431916 | chr9:117596862-117596863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs72756550 | chr9:117596872-117596873 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs545781658 | chr9:117596882-117596883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562616129 | chr9:117596904-117596905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 19147751 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ependymoma | 19289631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:117593000-117600000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr9:117593000-117600200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr9:117593200-117596600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr9:117593200-117596600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
5 | chr9:117593200-117598000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr9:117596600-117597800 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr9:117596600-117598000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
8 | chr9:117598000-117598600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr9:117598000-117598800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr9:117598000-117599200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
11 | chr9:117598400-117598600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr9:117598400-117598600 | Weak transcription | Pancreas | Pancrea |
13 | chr9:117598400-117598800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
14 | chr9:117598600-117598800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr9:117598800-117599000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr9:117598800-117602000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr9:117598800-117602000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |